Prevalence and Specificity of Anti-HPA and Anti-HLA Antibodies in Patients with Suspected Immune-Mediated Platelet Disorders: A Single-Center Study from Serbia
Medicina · 10.04.2026 · 62 (4) · 725
DOI: 10.3390/medicina62040725 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina, online erschienen am 10.04.2026. Verfasst von Svetlana Vojvodić und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusiology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia. Hauptthemen laut MEDLINE: Antigens, Human Platelet, Isoantibodies, HLA Antigens, Blood Platelet Disorders. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives: Alloantibodies directed against human platelet antigens and human leukocyte antigens are implicated in several immune-mediated platelet disorders, including platelet transfusion refractoriness, post-transfusion purpura and fetal and neonatal alloimmune thrombocytopenia. Reliable and simultaneous detection of these antibodies is essential for accurate diagnosis and appropriate clinical management. The aim of this study was to determine the prevalence and specificity spectrum of anti-HLA and anti-HPA alloantibodies in patients with suspected immune-mediated platelet disorders using a multiplex bead-based assay, and to evaluate its diagnostic utility in a Serbian cohort. Materials and Methods: A bead-based glycoprotein-specific antibody detection assay was performed using monoclonal antibodies specific for platelet glycoproteins and HLA class I molecules, separately coupled to Luminex microbeads. Serum samples were collected from 259 patients, including 234 patients with thrombocytopenia, 11 with neonatal alloimmune thrombocytopenia, and 14 with suspected platelet transfusion refractoriness. All samples were tested using the PakLx Luminex assay, and results were interpreted with MatchIt! Antibody software.
Results
Of the 259 tested samples, 72 (27.8%) were positive for HLA and/or platelet-specific antibodies. Among the positive samples, 29.2% contained HLA class I antibodies, 45.8% contained platelet-specific antibodies, and 25% showed combined HLA and platelet antibody positivity. The most frequently detected platelet-specific antibodies were directed against GPIIb/IIIa (HPA-1, -3, -4) and GPIa/IIa (HPA-5).
Conclusions
This first analysis of platelet alloantibodies in a Serbian cohort demonstrates a high prevalence of antibody positivity in patients with neonatal alloimmune thrombocytopenia and platelet transfusion refractoriness, with anti-HPA-1a as the predominant specificity. The significant association between clinical presentation and antibody profile underscores the need for targeted diagnostic testing. Multiplex bead-based technology provides comprehensive alloantibody detection, facilitating optimized transfusion management in immune-mediated platelet disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Transfusiology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.
- Blood Transfusion Institute of Vojvodina, 21000 Novi Sad, Serbia.
ORCID-Profile: Svetlana Vojvodić, Jasmina Grujić
Zitieren
APA
Vojvodić, S., & Grujić, J. (2026). Prevalence and Specificity of Anti-HPA and Anti-HLA Antibodies in Patients with Suspected Immune-Mediated Platelet Disorders: A Single-Center Study from Serbia. Medicina, 62(4), 725. https://doi.org/10.3390/medicina62040725
Vancouver
Vojvodić S, Grujić J. Prevalence and Specificity of Anti-HPA and Anti-HLA Antibodies in Patients with Suspected Immune-Mediated Platelet Disorders: A Single-Center Study from Serbia. Medicina. 2026;62(4):725. doi:10.3390/medicina62040725
BibTeX
@article{Vojvodi2026,
author = {Vojvodić, Svetlana and Grujić, Jasmina},
title = {Prevalence and Specificity of Anti-HPA and Anti-HLA Antibodies in Patients with Suspected Immune-Mediated Platelet Disorders: A Single-Center Study from Serbia},
journal = {Medicina},
year = {2026},
volume = {62},
number = {4},
pages = {725},
doi = {10.3390/medicina62040725}
}
EUVIMED